ARTICLE INFO The pharmacokinetic aspects of tulathromycin (2.5 mg/kg b.w.) were studied following intravenous administration alone and in combination with flunixin meglumine (2.2 mg/kg b.w) in apparently healthy goats. Tulathromycin concentrations in serum were determined by microbiological assay technique using Bacillus subtiles (ATCC 66343) as test organism. The half-lives of distribution and elimination (t 0 . 5 ( a )and to.5(p)) were 0.071, 0.046 and 6.43, and 5.05 h. following intravenous injection of tulathromycin alone and in combination with flunixin, respectively. Volume of distribution at steady state (Vdss) was 0.249 and 0.96l/kg., mean residence time (MRT) was 6.27 and 5.99 h and total body clearance (Cl B ) was 0.046 and 0.17 l/kg/hr., respectively. It was concluded that flunixin significantly altered the pharmacokinetics of tulathromycin by increase its distribution and accelerate its elimination from body. Therefore care should be taken during use of tulathromycin in goats concurrently with flunixin.
Introduction
Tulathromycin is a novel triamilide antimicrobial in the macrolide class shown to be safe and effective in cattle and swine to treat bacterial respiratory disease ( Robb et al., 2007) .
Non steroidal anti-inflammatory drugs (NSAIDs) are inhibitors of cyclooxygenase that catalyze the incorporation of molecular oxygen into arachidonic acid to produce prostanoids (eg, thromboxanes, prostacyclin, and prostaglandin) and are effectively administered for inflammation and pain. Flunixin is one of (NSAIDs) has been reported to reduce fevers and improve clinical signs of endotoxemia (Anderson et al., 1986) . Flunixin has been widely used for their anti-inflammatory and analgesic prosperities to treat the musculoskeletal conditions and colic in equine. It was also used routinely in ruminant practice to treat mastitis, endotoxemia and pneumonia (Zu-Gong et al., 2007). It is well documented that concurrent administration of drugs together may alter the pharmacokinetic parameters of these drugs. In veterinary practice the administration of antibiotics and NSAIDs at the same time was more common. Therefore, the aim of the study was to compare the disposition kinetic of tulathromycin in goats after a single intravenous administration alone and when administrated with flunixin meglumine. 
Material and Methods

Drugs
Animals:
Ten apparently healthy, male and female Egyptian goats (3-9 months old and mean body weight of (12-23 kg) were used. Animals were obtained from a local market at Beni-Suef province, kept under good hygienic condition, fed barseem and free access to water.
Methods:
Experimental design: The animals were randomly divided into two groups (five goats each). Animals of first group were injected intravenously with tulathromycin in alone single dose of2.5 mg kg 
Results:
Disposition of tulathromycin in serum after intravenous injection was best fitted by the 2-compartment open pharmacokinetic model (Figure 1) . The pharmacokinetic parameters of tulathromycin following a single intravenous administration of 2.5 mg kg -1 b.wt alone and with flunixin are recorded in table (1). The results of the present study revealed that tulathromycin was rapidly distributed following intravenous injection when administrated with flunixin where the distrubtionhalf lives were (t 0 . 5 ( a )) 0.071 when given alone and 0.046 h with flunixin. The body clearance (Cl B ) was 0.46 and 0.17 l/kg.h, the volume of distribution at steadystate (Vd ss ) was 0.249 and 0.96 L/kg, respectively. Pharmacokinetics of tulathromycin and its metabolite in swine administered with an intravenous bolus injection and a single gavage. Journal ofVeterinary Pharmacology and Therapeutics,35(3):282-289 Whittem, T., Firth, E.C., Hodge, H., and Turner, K., (1996) Zu-Gong, Y, J. Chun-Ao, G. Yong-Gang, H. Yi-Yi and C. Da-Jianl (2007) . pharmacokinetics of flunixinmeglumine after intravenous and intramuscular administration in pigs. Agric. Sci. Chin., 6: 1396-1401.
